2018 Canadian Obesity Student Meeting (COSM) Conference 2018
The Canadian Obesity Network is holding its 6th Canadian Obesity Student Meeting, known as COSM. The meeting will not only highlight important advances in obesity research but will also provide important opportunities for new professionals and trainees from across Canada to present findings and network with their peers.
The event will host 200 fellow young researchers and health professionals for three-four days of learning, networking and sharing information on all aspects of obesity. This multidisciplinary conference will be organized by the local CON-SNP chapter with guidance and support from the Canadian Obesity Network (www.obesitynetwork.ca). The presentations and discussions will range from cellular and molecular biology to childhood obesity, primary intervention, and population health. However, the primary purpose of this meeting is to enhance student growth and development. Organized by students, for students, this conference will give trainees the opportunity to showcase their work. Participants will come from across Canada, the USA and overseas. Open to 200 MSc/PhD students, young researchers, clinical fellows, clinical researchers and young health professionals in their last, or within five years of, completing their training.
7th Conference on Recent Advances in the Prevention and Treatment of Childhood and Adolescent Obesity: Beyond the Clinic
This conference brings together an interdisciplinary group of professionals working in the field of childhood and adolescent obesity. The 7th conference will focus on a range of topics that impact the prevention and treatment of obesity beyond the clinic setting, considering the broader social and environmental factors that influence the health of children, adolescents, and families. This multi-theme meeting will explore the role that health care professionals can play in promoting healthy strategies within the greater community to enhance the well-being of children and adolescents living with obesity. Specifically, the conference will showcase examples of successful collaborations that span diverse settings, including the health care system, government, schools, and community at-large.
CONFERENCE GOALS & OBJECTIVES
• Review the importance of community health and highlight successful strategies for promoting healthy lifestyles
• Analyze new trends in nutrition and healthy lifestyle aiming at preventing childhood and adolescent obesity
• Examine the role of social and environmental influences on obesity (e.g. social determinants of health; built environment; social network; media; technology)
• Provide a forum for networking and collaboration among health professionals, educators, researchers, policy makers, trainees and other stakeholders with an interest in childhood and adolescent obesity
• Highlight opportunities for attendees to promote healthy habits and environments in the broader community
CALL FOR ABSTRACTS
Deadline for Submissions: June 1, 2018
To submit an abstract or for more details, click here.
These seminars are now accredited for CME by the RCPC
2017-2018 Upcoming EMPhasis Events
December 14, 2017
Dr. Michael Surette - Farncombe Family Digestive Health Research Institute
|January 11, 2018||Dr. Scott Widenmaier- Department of Genetics and Complex Diseases, Harvard|
January 18, 2018
Dr. Stuart Phillips – Department of Kinesiology
February 1, 2018
Dr. Nikhil Pai – Department of Pediatrics
March 1, 2018
Dr. Kim Connelly - Keenan Research Centre for Biomedical Science
March 15, 2018
Dr. Sean Wharton - Wharton Medical Clinic
|March 29, 2018||TO BE ANNOUNCED|
|April 12, 2018||
|April 26, 2018||
|May 10, 2018||TO BE ANNOUNCED|
|May 24, 2018||
|June 7, 2018||TO BE ANNOUNCED|
Thursday December 14, 2017
12:00-1:00 - HSC 1A5
Speaker: Dr. Michael Surette
The microbiome as a driver and modifier of disease muddled by its underlying diversity
Michael Surette is a Professor and Canada Research Chair in Interdisciplinary Microbiome Research in the Department of Medicine and Department of Biochemistry and Biomedical Sciences at McMaster University. He is also director of the Farncombe Genomics Facility.
1. Recognize the microbiome as a driver and modifier of disease.
2. Understand the methods used to study the microbiome and basic comparative measurements used to characterize the microbiome.
3. Recognize the diversity of the human microbiome and limitations of methods for studying the microbiome.
2017 Past Events
Thursday November 30, 2017
Unilateral exercise models to study skeletal muscle: When is one limb more powerful than two?
Speaker: Dr. Martin MacInnis
Dr. MacInnis is a Postdoctoral Fellow in the Department of Kinesiology at McMaster University. He completed his PhD in environmental physiology at UBC before coming to McMaster to study skeletal muscle physiology with Dr. Phillips and Dr. Gibala. His research examines the effects of exercise, nutrition, and the environment on integrative human physiology, with a current focus on the factors regulating skeletal muscle mitochondrial density.
1. Review mitochondrial biogenesis.
2. Discuss the advantages and disadvantages of the unilateral exercise model.
3. Evaluate the roles of exercise intensity and duration in mediating changes in mitochondrial density.
Thursday November 16, 2017
The role of mast cell-derived serotonin in metabolic disease
Speaker: Julian Yabut, PhD Student
Julian completed his BSc in the Biology & Pharmacology Program at McMaster University and is now a PhD student under the supervision of Dr. Gregory Steinberg. His dissertation focuses on exploring sources of peripheral serotonin that mediate the progression of metabolic diseases such as obesity and type II diabetes.
1. Establish peripheral serotonin as a factor involved in regulating obesity, insulin resistance and fatty liver disease.
2. Uncover the relationship between mast cell-derived serotonin and metabolic disease using a mouse model.
Establishing the feasibility of mechanistic studies on the role of the immune system in adolescent idiopathic scoliosis
Speaker: Srikesh Rudrapatna, MSc Student
Srikesh is completing his M.Sc. under the supervision of Dr. M. C. Samaan in the Department of Pediatrics. His work focuses on bench to-bedside applications of research. On the clinical side, he is interested in understanding the application of rigorous research methods to help with knowledge synthesis, study design and evaluation. On the bench, he is interested in understanding the mechanisms of immune-muscle interactions in patients with adolescent idiopathic scoliosis (AIS).
1. Define the feasibility of translational research studies in AIS patients.
2. Knowledge synthesis; evidence for skeletal muscle macrophages in obesity.
3. Studying muscle immunometabolism in AIS.
Thursday November 2, 2017
A Molecular Whodunit: Targeting mediators of the systemic effects of exercise to treat metabolic disorders
Speaker: Dr. Ayesha Saleem
Dr. Ayesha Saleem completed her PhD at York University (2013) where her primary focus was to decipher the role of the sub-cellular localization of the tumor suppressor protein p53, in regulating skeletal muscle metabolic plasticity in the context of forced and volitional exercise. She completed her postdoctoral fellowship at McMaster University (2016), where she studied the use of extracellular vesicle biology as a therapeutic modality for genetic diseases, as well as investigating the therapeutic potential of pro-metabolic signalling factors to attenuate chronic pathological conditions such as obesity, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). She currently serves as a Professor in the School of Health Sciences (Biotechnology) at Humber College.
1. Learn about the putative mediators of exercise-induced whole body systemic adaptations.
2. Obtain insight into the underlying mechanisms by which pro-metabolic signalling factors attenuate metabolism-related disorders such as obesity, type 2 diabetes and NAFLD.
Thursday October 19, 2017
Microbial triggers of obesity-induced insulin resistance
Speaker: Dr. Kevin Foley
Dr. Kevin Foley completed his BSc and MSc in Kinesiology at the University of Waterloo where he studied exercise physiology. Dr. Foley then moved to the Biochemistry department at University of Toronto for his PhD where he studied cellular mechanisms of GLUT4 transport in the lab of Dr. Amira Klip in the Cell Biology Department at The Hospital for Sick Children. He is currently a postdoctoral fellow in the lab of Dr. Jonathan Schertzer. His research interests focus on mechanisms regulating the onset of obesity-induced insulin resistance. In particular, Dr. Foley is studying the role of the intestinal microbiota in mediating insulin resistance. His research encompasses both animal and cellular models to dissect pathways involved in mediating inflammatory responses in diet-induced obesity.
1. Present a mechanism through which inflammatory triggers stimulate lipolysis in a cell model.
2. Show that the intestinal microbiota can trigger defects in insulin dynamics, which may contribute to the onset of insulin resistance.
Thursday October 5, 2017
A critical understanding of NOD signalling in obesity, insulin resistance and gut microbial sensing; Important implications for re-tasking kinase inhibitors in diabetes treatment
Speaker: Brittany Duggan, PhD (Candidate)
Brittany is a PhD candidate under the supervision of Dr. Jonathan Schertzer. Her thesis explores the immunometabolic consequences of NOD1 and NOD2 signalling and how gut microbiota utilize these immune receptors to regulate host glucose and insulin homeostasis.
1. Define a role for NOD1 and NOD2 in gut microbial sensing and characterize functional effects of these pathways on glucose and insulin homeostasis.
2. Determine how kinase inhibitors currently under investigation for treatment of diabetes attenuate aspects of NOD1 and NOD2 signalling.
Myostatin inhibition therapy in the treatment of type 1 diabetes
Speaker: Samantha Coleman, PhD (Candidate)
Samantha completed her BMSc at the University of Western Ontario in Medical Biophysics. She is currently completing her PhD under the supervision of Dr. Thomas Hawke investigating the link between skeletal muscle health and type one diabetes using myostatin inhibition intervention.
1. Examining the impact of skeletal muscle on type 1 diabetic's health.
2. Investigating the role of inhibiting the myostatin pathway in the context of type 1 diabetes.
Thursday September 21, 2017
Are chemicals in our environment acting as metabolic endocrine disruptors?
Speaker: Dr. Alison Holloway
Dr. Holloway is a Professor in the Department of Obstetrics and Gynecology at McMaster University. Her research focuses on how exposure to various chemicals during pregnancy can affect long-term metabolic health of the offspring. The chemicals that are of interest to her laboratory include constituents of cigarette smoke, smoking cessation, pharmacotherapies and antidepressants. More recently, her group has also been investigating metabolic endocrine disruption by environmental toxicants.
1. Present evidence suggesting that chemicals in our environment are contributing to the obesity epidemic.
2. Discuss mechanisms by which these chemicals can cause obesity.
Thursday June 1, 2017
Nutrigenetics, omega-3 fats, and cardiometabolic health – Are we ready to personalize diets?
Speaker: Dr. David Mutch
Dr. Mutch is an Associate Professor of Nutrigenomics in the Department of Human Health & Nutritional Sciences at the University of Guelph, Canada. He received his PhD from the University of Lausanne Switzerland in 2005, and then completedpost-doctoral fellowships at The Scripps Research Institute in San Diego and the French National Institute for Health and Medical Research in Paris. In 2009 he joined the University of Guelph to establish a nutrigenomics research program to investigate the interactions between dietary fatty acids, inflammation and genes, and how this contributes to the development of obesity and obesity-related complications.
1. Introduction to nutrigenetics
2. Highlight the association between omega-3 fats and cardiometabolic health
3. Examine the role of fatty acid desaturase genes as mediators of omega-3 function
Thursday May 25th, 2017
Serotonin: a novel regulator of human erythroid progenitor cell expansion and its relevance to the development of myelodysplasia
Speaker: Francine Côté
Francine Côté is a research scientist within the Unit INSERM U1163 at Institut Imagine, Hôpital Necker, in Paris France. During her post-doctoral work, she generated the murine model deficient for 5-HT synthesis (Tph1-/-). Unexpected roles played by 5-HT in peripheral tissues were discovered using the Tph1-/- mouse line and led to the identification of complete serotonergic systems in unexpected locations. Within an organ, the presence of such a complete network is of importance as it highlights the link between local 5-HT synthesis and a precise function within the organ, rather than considering 5-HT as a pleiotropic hormone synthesized in the gut and distributed throughout the entire organism. With that in mind, her group is currently studying the physiological relevance of the serotonergic system within the human and mouse hematopoietic tissues and how the local system contributes to the emergence of hematological pathologies from early development to adult life.
Thursday May 18th, 2017
The relationship between brown adipose tissue and liver fat in adult humans
Speaker: Frank Ong, MSc Candidate
Frank Ong is a MSc student in Medical Sciences Graduate Program under the supervision of Dr. Katherine Morrison. His thesis explores the use of MRI in measuring brown adipose tissue (BAT) and its potential relationship with liver fat content.
1. The use of MRI in measuring BAT volume and activity
2. Relationship between MRI measures of BAT activity and liver fat content
The impact of adiposity on maternal cardiometabolic status throughout pregnancy and 6-months postpartum
Speaker: Valerie Bertram, MSc Candidate
Valerie completed her BSc at the University of Guelph in Biomedical Sciences. She is currently completing her MSc under the supervision of Dr. Stephanie Atkinson. Her thesis is focusing on the impact of adiposity on maternal cardiometabolic status in pregnancy and postpartum.
1. Known relationships between metabolism and maternal cardiometabolic status in pregnancy
2. The impact of adiposity on maternal metabolism and cardiometabolic status in pregnancy
Thursday May 4th, 2017
Adiposity in children with brain tumors: prevalence, predictors and interventions
Speaker: Kuan-Wen Wang, MSc Candidate
Kuan-Wen is a MSc student in Medical Sciences Graduate Program under the supervision of Dr. M. Constantine Samaan. Her thesis is focusing on evaluating the determinants of adiposity in children with brain tumors (CBT).
1. Examine predictors of adiposity in CBT compared to non-cancer controls
2. Summarize evidence on prevalence of obesity in CBT
3. Define current interventions for obesity in CBT
The effects of Fluvastatin on type 1 diabetic skin repair and muscle regeneration
Speaker: Irena Rebalka, PhD Candidate
Irena is a PhD student under the supervision of Dr. Thomas Hawke. Her thesis is focused on the effects of statins and novel therapeutics on wound repair in type 1 diabetes.
1. Introduce deficits in wound repair present in the type 1 diabetic environment
2. Examine how novel therapeutics and statins affect regeneration of diabetic tissue
5th Annual EMPhasis on Health Symposium
Date: Thursday April 20, 2017
Adipose Tissue: Regulation and Crosstalk: Featuring talks from experts in the field of Adipose Tissue
Dr. Emilio Mottillo, Wayne State University ~ Introduction to adipose tissue
Dr. David Meyre, McMaster University ~ Sex-specific patterns of genetic predisposition to obesity
Dr. Jon Schertzer, McMaster University ~ Microbiota control of adipose tissue inflammation and lipolysis
Dr. Robin Duncan, University of Waterloo ~ Phospholipids and the renal-adipose metabolic axis
Dr. Hoon-Ki Sung, Sick Kids, University of Toronto ~ VEGF in adipose tissue
Dr. Saswata Talukdar, Merck & Co. Inc. ~ FGF21 and its discovery from adipose tissue to CNS
Date: Thursday January 19, 2017
Oxidative stress and glutamate release in cancer pain
Speaker: Robert Ungard, PhD Candidate
Robert Ungard is a 2nd-year PhD student in the laboratory of Dr. Gurmit Singh at McMaster
University. He researches the impact of cancer-cell derived glutamate on metastatic cancer-induced bone pain.
Subclinical atherosclerosis in children with obesity enrolled in weight management
Speaker: Jenifer Li, MSc Candidate
Jenifer completed her BSc at the University of Waterloo in the Kinesiology Co-operative Education
Program with a minor in Human Nutrition. Her current work under the supervision of Dr. Katherine Morrison involves understanding determinants of carotid-intima media thickness which is a subclinical measurement associated with atherosclerosis.
Date: Thursday February 2, 2017
The effects of short-term energy restriction on muscle protein turnover
Speaker: Amy Hector, PhD Candidate
Amy completed her BSc at McMaster in the Biochemistry Coop program. She is currently completing her PhD in Medical Sciences under the supervision of Dr. Stuart Phillips. Her thesis focuses on the effects of resistance exercise and protein on muscle protein turnover during energy restriction.
1. Introduce muscle protein turnover
2. Examine how protein and exercise affect muscle protein turnover during dietary energy restriction
Radiosensitization of a radio-resistant prostate cancer cell line by AMPK activators metformin and salicylate
Speaker: Lindsay Broadfield, PhD Candidate
Lindsay is a PhD student under the supervision of Dr. Gregory Steinberg. Her thesis is focusing on the diabetic drug metformin on its anti-cancer effects in various models, and in combination with other treatments.
1. Mechanisms involved in anti-cancer effects of metformin, salicylate, and radiation therapy
2. Effect of combining metabolic treatments with radiation on prostate cancer models
Date: Thursday February 16, 2017
Mining genetics data for translational gold: bringing genomics to the cardiovascular clinic!
Speaker: Dr. Guillaume Pare
Dr. Guillaume Pare is an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University, and Director of the Genetic and Molecular Epidemiology Laboratory. Dr. Pare currently holds a Canada Research Chair in Genetic and Molecular Epidemiology, as well as a CISCO Professorship. His clinical interests are centered on lipoprotein disorders, obesity and cardiovascular disease prevention. His corresponding research interests are in cardiovascular genetics, biomarker development and pharmacogenomics. These interests have led to expertise in bioinformatics, high throughput biology and genetic epidemiology.
1. Understand principles of Mendelian randomization and its application to CV care.
2. Understand genomics testing in early coronary artery disease patients.
Date: Thursday March 1, 2017
5th ANNUAL RESEARCH BLITZ
Undergraduate and graduate studnets present their research in 1 minute!
Date: Thursday March 16, 2017
Serotonin and brown fat: Negative implications and potential interventions for metabolic disease
Speaker: Alex Green, PhD Candidate
Alex Green completed his undergraduate and master’s degrees in kinesiology at Queen’s and York University, respectively. Currently, he is a senior PhD candidate under the supervision of
Dr. Gregory Steinberg. He is investigating the role of serotonin on brown adipose tissue and developing novel therapeutics for treating metabolic diseases.
1. Highlight and understand effects of serotonin or brown adipose tissue
2. Identify a novel serotonin related intervention for improving metabolic disease
Optimizing overall health in aging: The use of multi-factorial exercise and nutrition strategies
Speaker: Kirsten Bell, PhD Candidate
Kirsten completed her MSc at the University of Waterloo where she investigated the interrelationships between body composition and glucose metabolism in early stage breast cancer. She is currently a PhD candidate under the supervision of Dr. Stuart Phillips. Kirsten's thesis examines how different
exercise modalities and nutritional supplements can be used to preserve strength, function, and lean mass in older age.
1. Question the applicability of “one-size-fits-all” exercise and nutrition prescriptions.
2. Recognize that sarcopenic strength and lean mass losses are not the only deleterious changes that accompany aging.
Date: Thursday April 6, 2017
Communication between immune cells and metabolic tissues contributing to insulin resistance
Speaker: Dr. Amira Klip
Dr. Amira Klip holds the Tier I Canada Research Chair on Cell Biology of Insulin Action. Dr. Klip is a Senior Scientist at The Hospital for Sick Children and a Professor of Pediatrics, Biochemistry and Physiology at University of Toronto. Her interests lie in the regulation of glucose uptake into muscle by insulin and muscle contraction, and conditions conferring insulin resistance (IR). This evolved to studying the contribution of fatty environments to activation of the immune system and its
consequence on muscle and adipose tissue IR. More recently, her group has also been investigating the transfer of insulin across endothelial cells. She has directed >40 students, 47 postdoctoral fellows and published >230 papers and 80 reviews.
1. Present the usefulness of cell culture to investigate cell to cell communication in the context of obesity.
2. Discuss the immune system sensors of the obese environment.
Date: Thursday December 15, 2016
Highlights and lessons learned from working in industry, and Reprogramming of lipid metabolism in cancer cells: An opportunity for therapeutic intervention?
Speaker: Steve Pinkosky
Steve Pinkosky has worked on the discovery of small molecule regulators of lipid and lipoprotein metabolism in the pharmaceutical industry for over 12 years.He is currently a PhD candidate in Dr. Greg Steinberg’s lab at McMaster University where he is investigating novel regulatory mechanisms of AMP-activated protein kinase (AMPK) and their role in the development and treatment of atherosclerosis.
Date: Thursday, December 8th, 2016
Nothing burns like the cold: exploring the metabolic and therapeutic implications of cold exposure in humans
Speaker: Dr. Denis Blondin
Dr. Denis Blondin completed his PhD from the University of Ottawa in 2014. He has spent the last 3 years as a Postdoctoral Fellow in the Department of Medicine at the University of Sherbrooke where his research has focused on characterizing BAT metabolism and its interaction with other organs in humans.
Date: Thursday, December 1st, 2016
Dietary factors modulating postprandial protein handling
Speaker: Dr. Stefan Gorissen
Dr. Gorissen is a postdoctoral researcher in the Department of Kinesiology at McMaster University. He obtained his PhD degree from Maastricht University, in the Netherlands, under supervision of Prof. Luc van Loon. His research focused on dietary components that affect protein digestion and amino acid absorption kinetics, as well as muscle protein synthesis rates.His current theme of research centers on the use of stable isotope tracers to study skeletal muscle protein turnover in response to immobilization in older adults.
Date: Thursday November 17th, 2016
More than Just Muscle: Beneficial Effects of Exercise on Adipose Tissue
Speaker: Dr. David Wright
Dr. Wright is an Associate Professor and Tier II Canada Research Chair in the Department of Human Health and Nutritional Sciences at the University of Guelph. Prior to coming to Guelph in 2010, Dr. Wright was an Assistant Professor at the University of Alberta and completed postdoctoral training at Washington University School of Medicine in St. Louis.
1. Review the classical literature linking inflammation to insulin resistance and diabetes.
2. Discuss the role of exercise as an approach to mitigate whole body and tissue specific inflammation.
3. Evaluate the necessity of white adipose tissue for the beneficial effects of exercise on whole body metabolism.
Date: Thursday November 3, 2016
Therapeutic modulations of cancer metabolism: laboratory bench to clinical trials
Speaker: Dr. Theos Tsakiridis
Dr. Tsakiridis is a Radiation Oncologist and Scientist at the Juravinski and the Walker Family Cancer Centres and Associate Professor with the Department of Oncology, McMaster University. His research interests involve understanding radiation biology and metabolism in lung and prostate cancer. He is involved in laboratory research investigating metabolism-modulating agents as radio-sensitizers and conducts national and international clinical trials with such compounds in lung cancer.
1. Review therapeutic challenges in lung & prostate cancer.
2. Discuss molecular response of tumors to radiotherapy & impact on tumor growth, cell cycle control and metabolism.
3. Review pre-clinical evidence supporting targeting of metabolism in combination with cytotoxic therapy & current clinical trails investigating this in lung cancer.
Date: Thursday October 20, 2016
An unconventional academic journey: from cardiovascular dynamics to muscle metabolism (and everything in between)!
Speaker: Dr. Tanya Holloway
Date: Thursday October 6, 2016
EXERSOMES: Good things come in small packages
Speaker: Dr. Adeel Safdar
Dr. Adeel Safdar completed his PhD evaluating the systemic benefits of exercise in murine models of mitochondrial pathology and aging at McMaster University. His current Postdoctoral Fellowship in Dr. Mark Tarnopolsky's lab at McMaster University involves characterization of the proteins, mRNA, and MiRNA cargoed in extracellular vesicles as mediators of organ cross-talk to modulate the pro-metabolic affects of endurance exercise.
1. Introduction to extracellular vesicles
2. Examining the role of extracellular vesicles as mediators of multisystem cross-talk
Date: Thursday September 15, 2016
Salicylate-based drugs: The mechanism of action revisited
Speaker: Dr. Brennan Smith
Dr. Brennan Smith completed his PhD investigating the regulation of skeletal muscle metabolism at the University of Guelph in 2013. His current Postdoctoral research in Dr. Gregory Steinberg's lab at McMaster University involves studying the mechanism(s) by which pharmaceuticals produce their beneficial effects.
1. Introduce mitochondrial bioenergetics
2. Examine how salsalate reduces type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
Date: Monday August 15, 2016
Brown Adipose Tissue in Humans: embracing the cold and the controversies in targeting BAT for the management of metabolic diseases
Speaker: Denis P. Blondin, Posdoctoral Fellow (University of Sherbrooke)
Date: Thursday June 16, 2016
Defining the roles of Xin, a striated muscle specific protein, in skeletal muscle
Presented by: Dhuha Al-Saji, PhD (Candidate)
Dhuha received her medical degree from Al-Nahrain University, College of Medicine in Baghdad, Iraq. She then went on to complete speciality training in Anatomical Pathology. She is currently a PhD candidate under the supervision of Dr. Thomas Hawke, studying the roles of Xin in skeletal muscle.
Determining the Impact of NLRP3 Inflammasome Activation in Statin Myopathy
Presented by: Emily Li, MSc (Candidate)
Emily completed her BSc at McMaster University in the Biology and Pharmacology Program. She is currently completing her MSc in Medical Sciences under the supervision of Dr. Jonathan Schertzer. Her thesis is focused on understanding how the NLRP3 immune receptor might contribute to statin-induced muscle pain.
Date: Thursday May 19, 2016
Obesity predisposing genes and risk of type 2 diabetes in a multiethnic study
Presented by:Adeola Ishola, MSc (Candidate)
Adeola Ishola completed her BSc at McMaster University in Biology and is currently completing her MSc in Medical Science under the supervision of Dr. David Meyre. Her thesis examines the pleiotropic effect of obesity predisposing genes on metabolic complications in multiethnic populations.
The role of AMPK in Placental Angiogenesis
Presented by: Patrick Rodriguez, MSc (Candidate)
Patrick completed his B.Sc. in Medical Sciences at Brock University and is currently completing his M.Sc. in Medical Sciences at McMaster University under the supervision of Dr. Sandeep Raha. His thesis focuses on the role of AMPK in placental angiogenesis and how manipulating AMPK activity leads to alterations in angiogenic processes in vitro.
Date: Thursday May 5, 2016
Reactive oxygen species in health and disease: toxins or essential signals?
Presented by: Dr. Christopher Perry, PhD
Dr. Christopher Perry is from the Muscle Health Research Centre at York University, where he is currently an Assistant Professor in the Department of Kinesiology. His group examines the role of mitochondria as critical regulators of muscle metabolism and redox homeostasis in various models, including exercise and muscle wasting diseases (muscular dystrophies and cancer cachexia). The goal of his research is to use metabolic-redox signaling in adaptive processes as a foundation to test novel therapeutics for the treatment of mitochondrial-linked pathologies.
Date: Thursday April 7, 2016
Metabolic flexibility in children with obesity: Exercise as a screening test and a treatment
Presented by: Lisa Chu, PhD (Candidate)
Lisa Chu completed her BSc in Kinesiology at McMaster University and went on to complete her MSc at York University. There, she worked with a collaborative childhood obesity research team at SickKids hospital. She then returned to McMaster for her PhD in Medical Sciences under the supervision of Dr. Brian Timmons. Her thesis focuses on metabolic flexibility during exercise in children.
Metabolism of intrinsically labeled egg proteins at rest and after endurance exercise
Presented by: Michael Mazzulla, MSc (Candidate)
Michael Mazulla completed his BSc at York University in Kinesiology and Health Science and is currently completing his MSc in Exercise Sciences under the supervision of Dr. Dan Moore at the University of Toronto. His thesis examines the metabolism of intrinsically labeled egg proteins at rest and after endurance exercise.
Date: Thursday March 17, 2016
Optimizing the Metholodogy for the Detection of Brown Adipose Tissue using Infared Thermography
Speaker: Tahniyah Haq, MSc (Candidate)
Tahniyah Haq completed her medical degree and trained in adult Endocrinology at the University of Dhaka in Dhaka, Bangladesh. She is currently completing her Master's degree in Medical Sciences under the supervision of Dr. Gregory Steinberg. Her thesis focuses on optimizing the methology for the measurement of brown adipose tissue in adult humans.
Fatty Acid Profiles in Nutrition Sources and Blood for Newborn Infants
Speaker: Arum Choi, MSc (Candidate)
Arum Choi completed her H.BSc in Life Sciences at McMaster University. She is currently completing her MSc in Medical Sciences under the supervision of Dr. Christoph Fusch. Her thesis focuses on fatty acid profiles in nutrition sources and plasma in order to understand the condition of high triglyceride levels in newborn infants.
Date: Thursday March 10, 2016
Magnetic Resonance Imaging of Brown Adipose Tissue
Speaker: Dr. Charlie McKenzie, PhD
Dr. Charles McKenzie is an Associate Professor of Medical Biophysics visiting from the SchulichSchool of Medicine and Dentistry at Western University. He is currently the Canada Research Chair in Translational Magnetic Resonance Imaging Research and holds Associate Scientist appointments at the Children's Health Research Institute, RobartsResearch Institute and Lawson Health Research Institute in London, Ontario. Dr. McKenzie’s talk will discuss methods of using MRI to identify brown adipose tissue (BAT) depots, quantify their change over time, and explore emerging methods to use MRI to investigate BAT metabolism.
Date: Thursday March 3, 2016
Salsalate reduces atherosclerois via an AMPK β1 dependent pathway
Speaker: Emily Day, MSc (Candidate
Emily Day completed her H.BSc here at McMaster University in Biochemistry with and specialization in Biomedical Sciences. She is currently completing her Master's Degree in Medical Sciences under the supervision of Dr. Gregory Steinberg examining the role of AMPK in the development of atherosclerosis.
Predicting Preterm Infants' Individual Growth Trajectories Using an Innovative Growth Trajectory Calculator Tool
Speaker: Erin Landau-Crangle, MSc (Candidate)
Erin completed her H.BSc in Life Sciences at McMaster, and is currently completing her MSc in
Medical Sciences with Dr. Christoph Fusch in the Division of Neonatology. Her thesis focuses on
characterizing growth of preterm infants. Erin is developing a “Growth Trajectory Calculator” tool to
predict individualized growth trajectories in order to prevent negative health outcomes in later life.
Date: Thursday January 28, 2016
Thermogenic control of brown and beige fat mitochondria
Speaker: Dr. Lawrence Kazak, PhD
Dr. Lawrence Kazak is a postdoctoral fellow in the laboratory of Bruce Spiegelman at Harvard Medical School. His research interests are focused on energy homeostasis in mammals, primarily at the level of mitochondrial metabolism. He obtained his Ph.D. from Cambridge University where he worked in the laboratory of Ian J. Holt, studying DNA replication and protein trafficking in mitochondria. During his postdoctoral research, he has identified a thermogenic role for creatinein brown and beige adipose tissue. His current research efforts are directed towards the development of genetic mouse models and metabolic tracing methods to elucidate the molecular determinants of adipose thermogenesis and to delineate the role of this process in promoting metabolic health.
Date: Thursday January 21, 2016
More than Gluco-Regulation? Cardio-Renal Hemodynamic Effect(s) of Anti-Hyperglycemic Agents
Speaker: Dr. Julie A. Lovshin, MD, PhD, FRCPC
Lovshin is a post-doctoral research fellow in the Department of Endocrinology and Metabolism at the University of Toronto in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital. She received her medical degree and specialized in Internal Medicine and Endocrinology and Metabolism from the University of Toronto. There, she also obtained her PhD in the laboratory of Dr. Daniel Drucker, where she studied GLP-2, GLP-1 and gut hormones. She is now completing a post-doctoral research fellowship in Human Clinical Investigation. Her current research focuses on defining mechanisms of cardio-renal effect(s) of incretin-based diabetes therapies and SGLT-2 inhibitors in patients with Diabetes Mellitus.
Date: Thursday January 7, 2016
Role of Energy Sensing Pathways in Adipose Tissue
Time: 12-1 pm
Speaker: Dr. Emilio Mottillo
Dr. Mottillo completed his PhD at Wayne State University in Detroit, Michigan, where he received CIHR doctoral funding. There, he studied the enzymes involved in lipid hydrolysis, focusing on mechanisms by which white fat is converted to brown adipose tissue. With the goal of further understanding energy sensing pathways in adipose tissue, Dr. Mottillo pursued post-doctoral training at McMaster University with Dr. Gregory Steinberg. He is currently looking at the role of important energy sensor AMP-activated kinase (AMPK) in adipose tissue. He is funded by a post-doctoral fellowship from the Canadian Diabetes Association.
Date: Thursday December 17, 2015
The effects of obesity on adipose tissue resident stem cells
Speaker: Dr. Eva Szabo, PhD
Dr. Eva Szabo joined McMaster University in the Stem Cell and Cancer Research Institute (SCC-RI) as Assistant Professor in January 2013. Dr. Szabo's overarching research aim is to understand the molecular and functional aspects involved in the development of obesity, as well as establish alternative treatment strategies to alleviate its burden and downstream complications, such as Type 2 diabetes and neuropathy. She currently holds a Tier 2 Canada Research Chair in Metabolism in Human Stem Cells and Cancer Development.
Date: Thursday December 3, 2015
Transcriptional control of brown and beige adipose cell fate
Visiting Speaker: Dr. Patrick Seale, PhD, University of Pennsylvania
Dr. Patrick Seale is an Assistant Professor in the Department of Cell and Developmental Biology at the University of Pennsylvania. He obtained his PhD from McMaster University in the laboratory of Dr. Michael Rudnicki. He went on to do postdoctoral research with Bruce Spiegelman at Harvard Medical School. There, he identified PRDM16 as a dominant driver of brown fat cell differentiation and discovered that brown fat and muscle originate from a common lineage during development. His current research program continues to focus on the molecular mechanisms that control the biology of adipose tissues and on the role of brown fat in metabolic disease.
Date: Thursday November 19, 2015
New insights into mechanisms of vascular calcification
Visiting Speaker: Dr. Gabriel Gyulay, PhD
Dr. Gabriel Gyulay completed his doctoral degree in Molecular Biology and Human Genetics under the supervision of Dr. Suleiman Igdoura at McMaster University. He is currently pursuing a post-doctoral fellowship at the Hamilton Centre for Kidney Research with Dr. Richard Austin, where he is examining molecular mechanisms of vascular calcification and its role in renal disease and metabolic syndrome. His talk will outline novel cellular and molecular targets of calcification in disease progression.
Date: Thursday November 5, 2015
Postnatal catch-up grown and the Metabolic Syndrome: Elucidating the underlying mechanism
Visiting Speaker: Dr. Daniel Hardy, PhD
Dr. Daniel Hardy is an Associate Professor in the Departments of Ob/Gyn and Physiology and Pharmacology at Western University. After completing his PhD at Western University, he pursued a post-doctoral fellowship at the University of Texas Southwestern Medical Center, where he focused on actions of steroid hormone receptors. Since returning to Canada, he has been recognized as the 2014 "Scientist of the Year" by Children's Health Research Institute. His current laboratory examines the molecular mechanisms underlying the fetal origins of adult onset diseases.
Date: Thursday October 15, 2015
Therapeutic potential of heat shock protein induction for muscle wasting disorders
Visiting Speaker: Dr. Gordon Lynch, PhD, FACSM, CSCS
Dr. Lynch is from the University of Melbourne, where he is the head of the Department of Physiology. He presented an update on the therapeutic potential of the small molecule BGP-15 for Duchenne muscular dystrophy and described the 'window of opportunity' for different interventions for this and related muscle wasting disorders, including a role for exercise.
Date: Thursday October 1, 2015
Impact of Diabetes Melittus and Associated Changes on the Satellite Cell
Donna D’souza completed her MSc. at York University studying mitochondrial biogenesis, and is currently completing her PhD in Medical Sciences under the supervision of Dr. Thomas Hawke. Her thesis examines the relationship
between Diabetes Mellitus and the skeletal muscle satellite cell.
Identifying new genetic variants of obesity in multi-ethnic cohorts from both body adiposity index (BAI) and body mass index (BMI)
Speaker: FerestehTabatabaei, MSc Candidate
Feresteh Tabatabeai completed her BSc at McMaster University in Life Sciences with a minor in psychology. She went on to complete a BHS in Health Management at York University before returning to McMaster for a MSc in Medical Sciences focusing on genetic epidemiology of obesity with Dr. David Meyre. Her thesis will focus
on the discovery of new genetic variants of obesity.
Date: Thursday June 11, 2015
Speaker: Martin MacInnis, PhD0>
Dr. Martin MacInnis is an NSERC postdoctoral fellow in the Exercise Metabolism Research Group (Department of Kinesiology, McMaster). His research is focused on human physiology in the contexts of hypoxia and exercise. As part of his PhD, Martin conducted research in the Himalayas and Andes focused on acute altitude illness. He is currently investigating the process of skeletal muscle remodelling in response to various aerobic training protocols.
Speaker: Linda Villani, MSc Candidate
Linda completed her HBSc in Biology at York University and is currently working under the supervision of Dr. Gregory Steinberg and Dr. Theos Tsakiridis at McMaster. She will be presenting her work on the anti-cancer effects of new medications currently used for the treatment of diabetes.
Date: Thursday May 21, 2015
Remission of Type 2 Diabetes: Insights from the REMIT Pilot Trial
Natalia McInnes received her medical degree from the University of British Columbia in 2004. She pursued an MSc in Health Research Methodology at McMaster University and was recently hired as an Assistant Professor in the Division of Endocrinology, Department of Medicine. Her research interests include remission of pre-diabetes and type 2 diabetes, and the relationship between dysglycemia and ectopic fat deposition.
Date: Thursday April 30, 2015
Speaker: Katarina Marcinko, PhD (Candidate)
Katarina Marcinko completed her MSc at McMaster University, and is currently completing her PhD in the Medical Sciences Graduate Program under the supervision of Dr. Gregory Steinberg. Her thesis examines the effects of AMPK activation in high-fat diet induced insulin resistance.
Speaker: Adam Bujak, PhD (Candidate)
Adam Bujak is currently completing his PhD in the Medical Sciences Graduate Program under the supervision of Dr. Gregory Steinberg. Adam will be presenting work on his research investigating how energetic stress and autophagy regulates fastinginduced glycemia and muscle health during aging.
Date: Thursday April 30, 2015
Speaker: Robyn Pereira, MSc (Candidate)
Robyn Pereira completed her BSc in Biology at Queen's University, and is currently completing her MSc in the Medical Sciences Graduate Programme under the supervision of Dr. Sandy Raha. She will be presenting her work on understanding how an antipsychotic drug impacts placenta developement.
Speaker: Anaam Ali, MSc (Candidate)
Anaam Ali completed her BSc in Life Sciences at McMaster University, and is currently completing her MSc in the Medical Sciences Graduate Programme under the supervision of Dr. Christopher Fusch. Her research focuses on neonatal nutrition and body composition.
Date: Thursday April 23, 2015
Date: Thursday April 2, 2015
Speaker: Val Fajardo, PhD (Candidate), University of Waterloo
Val completed his MSc degree with Dr. Paul LeBlanc at Brock University, and is currently completing his PhD under the supervision of Dr. Russell Tupling at the University of Waterloo. His research focuses on Ca2+ regulation in skeletal muscle health and disease.
Speaker: Sarah Kanji, MSc (Candidate)
Sarah completed her HBSc in Biology at McMaster University, and is currently completing her MSc under the supervision of Dr. Katherine Morrison. She will be presenting her work on understanding the role of brown
adipose tissue in child health.
Speaker: Vanessa Houde, Ph.D.
Date: Thursday March 19, 2015
Dr. Vanessa Houde completed her PhD under the supervision of Dr. André Marette at Laval University. Following this, Dr. Houde completed her first post doctoral fellowship at the MRC Protein Phosphorylation Unit at the University of Dundee (Scotland) with Dr. Dario Alessi. She is currently completing her second postdoctoral fellowship under the co-supervision of Drs. Gregory Steinberg and Paola Muti at McMaster University.
Speaker: Michaela Devries-Aboud, Ph.D.
Date: Thursday March 5, 2015
Dr. Michaela Devries completed her PhD under the supervision of Dr. Mark Tarnopolsky at McMaster University. She worked clinically for 4 years with a family health team (FHT), and then returned to McMaster in 2013 to begin a postdoctoral fellowship with Dr. Stuart Phillips in the Department of Kinesiology. Dr. Devries will be presenting work outlining how resistance exercise, protein and nutritional supplements can help offset the declines in muscle mass and strength that accompany aging.
Speaker: Rokhsana Mortuza, Ph.D.
Date: Thursday February 19, 2015
Dr. Rokhsana Mortuza completed her PhD under the supervision of Dr. Subrata Chakrabarti at Western University. She is currently completing her postdoctural research with Dr. Gregory Steinberg at McMaster University. Dr. Mortuza will be presenting her PhD work on identifying a novel SIRT-mediated rapid aging process in diabetes leading to renal and retinal damage.
Speaker: Giovanni Blandino, M.D., M.Sc.
Date: Thursday February 5, 2015
Dr. Blandino is currently the Head of the Translational Oncogenomics Laboratory in the Department of Molecular Medicine at the Regina Elena Cancer Institute in Rome, Italy. His research seeks to understand the molecular mechanisms of gain-of-function mutant p53 proteins. More recently, his research focuses on microRNAs as both powerful biomarkers for prevention and treatment of human tumours, and non-coding mediators of metformin-induced anti-cancer metabolic effects.
Date: Thursday January 22, 2015
Speaker: Anna Vainshtein
Anna Vainshtein is a doctoral student in the lab of Dr. David Hood at York University. The objective of her work is to ascertain the role of the transcriptional co-activator PGC-1α in the regulation of autophagy in skeletal muscle. Autophagy is a recycling mechanism that is vital for cellular homeostasis and is activated during metabolic and contractile alterations in muscle. The main focus of her research is to investigate how PGC-1α modulates autophagy and co-ordinates the fine-tuning of mitochondrial density during muscle disuse, nutrient deprivation and exercise.
Date: Thursday December 18, 2014
Each year, the CON-SNP @ Mac and MAC-Obesity Research Program host an exciting event called Research Blitz. The Annual Research Blitz is an opportunity for graduate students to speak about their research in one minute. Each year, close to 20 graduate students from various faculties across campus participate. The Blitz provides a great opportunity to learn about the wide array of nutrition, obesity and exercise related research being conducted at the university, and also connects graduate students with their peers.
Date: Thursday December 4, 2014
Speaker: Dr. Kevin Foley, PhD
Dr. Kevin Foley completed his PhD in the department of Biochemistry at the University of Toronto studying mechanisms regulating the intracellular sorting of GLUT4 in muscle cells under the supervision of Dr. Amira Klip. His current postdoctoral research under the supervision of Dr. Jonathan Schertzer at McMaster University involves studying how NOD proteins link inflammation to obesity-induced insulin resistance.
Date: Tuesday November 25, 2014
Speaker: Professor D. Grahame Hardie, Division of Cell Signalling and Immunology (CSI), College of Life Sciences, University of Dundee, Scotland
Dr. Hardie is one of the world's preeminent biochemists. His discovery and naming of the AMP-activated protein kinase (AMPK) 27 years ago has had an impact all nearly areas of biology. His subsequent discoveries that AMPK was activated by exercise and many commonly used medications have had a profound effect on our understanding of metabolism in health and disease.
AMP-activated protein kinase (AMPK) is a key regulator of energy balance at the cellular and whole body levels that is expressed in essentially all eukaryotic cells. The target-of-rapamycin (mTORC1) and AMPK systems are mutually antagonistic signalling pathways whose regulation are intricately linked, and which may both have arisen very early during eukaryotic evolution. AMPK is activated by starvation for glucose and other stresses that deplete cellular ATP, as well as by many drugs and natural products with medicinal properties. The latter include the anti-diabetic drug metformin that was derived from a herbal remedy, the natural product salicylate from which aspirin was derived, and many compounds used in traditional Asian medicines. Given the fundamental role of AMPK is modulating cell metabolism, it is not surprising that it has key roles in chronic human diseases such as obesity, diabetes, cancer and inflammatory disease.
Date: Thursday November 20, 2014
Speaker: Vladimir Ljubicic, PhD
Dr. Vladimir Ljubicic is an Assistant Professor and Canada Research Chair in Neuromuscular Plasticity in Health and Disease in the Department of Kinesiology at McMaster University. His laboratory investigates mechanisms of neuromuscular maintenance and remodelling, with an emphasis on identifying new therapeutic targets for neuromuscular disorders. A goal of his research is to decipher how interventions such as physical activity, experimental small molecules, and common generic medications can be used to slow, prevent, or reverse neuromuscular pathologies.
Date: Thursday November 6, 2014
Speaker: Murray Huff, PhD
Dr. Murray Huff is currently a Professor in the Departments of Medicine and Biochemistry, and the Director of the Vascular Biology Research Group at the Robarts Research Institute at Western University. His research focuses on the relationship between lipoprotein metabolism and atherosclerosis. Through his research, Dr. Huff has elucidated the action of a variety of cholesterol-lowering drugs, including statins.
Date: Thursday October 23, 2014
Speaker: Chris McGlory, PhD
Dr. Chris McGlory completed his PhD investigating the impact of n-3 PUFA supplementation on muscle protein synthetic response to feeding and exercise at the University of Stirling, Scotland. His current postdoctoral research under the supervision of Dr. Stuart Phillips involves investigating the cellular and molecular mechanisms of muscle disuse atrophy as well as nutritional interventions aimed at combatting muscle mass loss with age.
Date: Monday October 6, 2014
Speaker: Arya Sharma, MD/PhD, DSc (hc), FRCPC
Dr. Arya Sharma was recruited in 2002 from Humbolt University, Berlin, Germany to a Canada Research Chair (Tier1) in Cardiovascular Obesity and Management at McMaster University. In 2007, he accepted a position as professor and Chair in Obesity Research and Management at the University of Alberta, where he is also the Medical Director of the Edmonton Regional Bariatric Program. In 2005, he spearheaded the launch of the Canadian Obesity Network. His research focuses on an evidence-based approach to managing obese patients.
Date: Thursday September 11, 2014
Speaker: Adeel Safdar, Ph.D.
Dr. Adeel Safdar completed his PhD studies under the supervision of Dr. Mark Tarnopolsky at McMaster University. His doctoral work focused on investigating the endurance exercise-mediated therapeutic modulation of systemic mitochondrial biogenesis in aging. His recent postdoctoral research with Dr. Zoltan Arany at Harvard Medical School involved deciphering the molecular cues underlying the anti-tumorigenic effects of endurance exercise. Dr. Safdar will present data on a PGC-1α-dependent myokine that mitigates breast cancer and melanoma.
Date: Thursday June 5, 2014
Speaker: Imtiaz Samjoo, PhD
Dr. Imtiaz Samjoo completed his graduate research (MSc, PhD) at McMaster University investigating the influence of adiposity and mitochondrial DNA mutations on continuous glucose monitoring, endurance exercise and intramyocellular lipid content and their roles in insulin signalling. Currently, Imtiaz is an experienced healthcare professional, specializing in health economics and outcomes research, reimbursement and market access strategy, medical communications, and medical marketing at a private healthcare consulting firm.
Speaker: Michaela Devries-Aboud, PhD
Dr. Michaela Decries-Aboud completed her PhD at McMaster University with Dr. Mark Tarnopolsky investigating the effects of sex, estrogen and obesity on carbohydrate and fat metabolism. Michaela then worked with the Program in Evidence-Based Care at McMaster University and the Guelph Family Health Team. Michaela decided to return to academia and is currently a Postdoctoral Fellow with Dr. Stuart Phillips in the Department of Kinesiology where she is investigating how nutrition and physical activity/inactivity influences muscle protein synthesis and muscle mass in older adults.
Date: Thursday May 29, 2014
Speaker: Melissa Thomas, PhD
Dr. Melissa Thomas completed her PhD investigating adaptations of aged skeletal and cardiac muscle to exercise training at the University of Calgary. Her current postdoctoral research under the supervision of Dr. Thomas Hawke at McMaster University involves studying the effect of high fat diet on skeletal muscle health and response to injury. Dr. Thomas will present on adaptations of growing skeletal muscle to a high fat diet.
Speaker: Anna Romashkin, MSc Candidate
Anna is a second year Master's student in Dr. Katherine Morrison's lab, completing her undergraduate HBSc at the University of Toronto in Physiology and Human Biology. Her current research focuses on sleep and its relationship with physical activity and metabolic health in overweight youth enrolled in lifestyle management programs.
Date: Thursday May 15, 2014
Speaker: Anne Gilsing, PhD
Anne Gilsing recently completed her PhD in nutritional cancer epidemiology at Maastricht University, the Netherlands. During her PhD, she worked for five months at the US National Cancer Institute. Her research involves the investigation of dietary components (in particular meat consumption) and their relation to the development of cancer. Anne will present result from her doctoral studies.
Date: Thursday April 17, 2014
Speakers: Deborah Slobada, PhD; Katherine Morrison, MD; Stephanie Atkinson, PhD; Sonia Anand, MD, PhD and Special Guest Speaker from Brock University - Wendy Ward, PhD
Date: Thursday April 3, 2014
Speaker: Maria Restivo, Ph.D. Candidate
Maria Restivo graduated from the University of Toronto with a joint degree in Biochemistry and Psychology. She is currently completing her Ph.D. in clinical neuroscience at McMaster University. Her research interests include the interactions between weight and cardiovascular health, cognitive function, and mood disorders, and the application of brain imaging techniques in understanding cerebral mechanisms underlying the neurobiology of psychiatric illness.
Date: Thursday March 20, 2014
Speaker: Dr. Justin Crane, Ph.D.
Dr. Justin Crane completed his undergraduate degree at Rutgers University. He subsequently completed his Master's degree at Ball State University and his PhD at McMaster University studying the effects of aging and exercise on mitochondrial metabolism. Dr. Crane is currently working as a post-doctoral fellow in the MAC-Obesity research group studying the regulation of brown adipose tissue in obesity.
Date: Thursday March 6, 2014
Speaker: Dr. Gregory Wohl, Ph.D.
Dr. Gregory Wohl is an Associate Professor in the Department of Mechanical Engineering at McMaster University. His research focuses on adaptation of bone to external stimuli and the influence of diet and pharmaceutical therapies. Dr. Wohl will present his research on the effects of obesity and a high fat diet on bone repair and adaptation.
Lipolytic Products Integrate Metabolism in Brown and White Fat
Date: Thursday February 20, 2014
Speaker: Dr. Emilio Mottillo, Ph.D.
Dr. Emilio Mottillo completed his undergraduate and Masters degree at the University of Windsor. He then completed his Ph.D. at Wayne State University under the supervision of Dr. James Grannemnan, where he studied the pathways that convert white fat to brown fat. Dr. Mottillo is now working with Dr. Greg Steinberg at McMaster University examining the role of AMPK in adipose tissue.
Date: Thursday February 6, 2014
Speaker: Dr. Brennan Smith, PhD
Dr. Brennan Smith completed his PhD investigating the regulation of mitochondrial fatty acid oxidation at the University of Guelph. His current postdoctoral research under the supervision of Dr. Greg Steinberg at McMaster University involves studying the regulation of immunometabolism. Dr. Smith will present on mitochondrial metabolism in skeletal muscle and inflammatory tissue.
Date: Thursday January 16, 2014
Speaker: Dr. Morgan Fullerton, Ph.D.
Dr. Fullerton completed his PhD work at the University of Guelph, investigating phospholipid metabolism. His postdoctural work has involved characterizing the role of AMP-activated protein kinase (AMPK) signaling in metabolic disease. He will be starting his own research program at the University of Ottawa this summer.
Date: Thursday November 28, 2013
Antidepressant Use During Pregnancy and the Risk of Obesity in the Offspring: Role of Gut Microbiota
Speaker: Harriet Law
Harriet Law is a MSc student in the Department of Medical Sciences, working under the supervision of Dr. Alison Holloway. She developed an interest in the developmental origins of health and disease during her undergrad in Biology at McMaster University. Harriet's current research focuses on understanding the metabolic outcomes of offspring exposed to antidepressants in utero.
Speaker: Sabina Shin
Sabina Shin is a MSc student in the Department of Medical Sciences, working under the supervision of Dr. Katherine Morrison. She completed her undergraduate degree in Honours Biology at McMaster University. Sabina's research focuses on the influence of sociodemographic and biological factors on depression in youth enrolled in a weight management program.
Date: Thursday November 14, 2013
Speaker: Dr. Shao-Ling Zhang, Ph.D.
Dr. Shao-Ling Zhang is an associate professor in the Faculty of Medicine at the Université de Montréal. She obtained her Bachelor of Medicine from Shanghai Medical University, and her MSc and PhD from the Université de Montréal. Dr. Zhang then completed her post-doctoral training at the Massachusetts General Hospital at Harvard Medical School before being recruited back to the Université de Montréal as an independent investigator. Her research focus includes maternal diabetes and perinatal programming of kidney and cardiovascular disease.
Date: Thursday October 31, 2013
Speaker: Dr. Anthony Bruce, Ph.D.
Dr. Anthony Bruce received his Masters degree in Molecular Biology of Cancer under the supervision of Dr. Andre Bedard at York University. He recently completed his PhD under the supervision of Dr. Damu Tang in the Department of Medicine, Cancer and Genetics at McMaster University. Dr. Bruce will discuss the characterization of a novel microsomal heme binding protein that modulates sterol synthesis through the cytochrome P450 system.
Date: Thursday October 3, 2013
Speaker: Dr. Ayesha Saleem, Ph.D.
Dr. Ayesha Saleem is a postdoctural fellow at McMaster University and completed her Ph.D. at York University under the supervision of Dr. David Hood. Ayesha's research focuses on the tumor suppressor protein p53 and its involvement in regulating mitochondrial function and exercise capacity. Her talk will provide mechanistic insight into the role of p53 in determining basal and exercise-induced mitochondrial biogenesis in skeletal muscle.
Date: Thursday September 12, 2013
Speaker: Dr. Saswata Talukdar, PhD
Dr. Saswata Talukdar completed his doctoral studies at West Virginia University investigating metabolism and pathophysiology associated with metabolic dysfunction. During his postdoctural training at the University of California, he left behind in vitro work and became an in vivo physiologist. Dr. Talukdar is currently a principle scientist at Pfizer conducting research on treatment for type 2 diabetes mellitus.